These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31054517)

  • 1. De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy.
    Xie H; Su W; Pei J; Zhang Y; Gao K; Li J; Ma X; Zhang Y; Wu X; Jiang Y
    Epilepsy Res; 2019 Aug; 154():55-61. PubMed ID: 31054517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
    Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
    Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison and optimization of in silico algorithms for predicting the pathogenicity of sodium channel variants in epilepsy.
    Holland KD; Bouley TM; Horn PS
    Epilepsia; 2017 Jul; 58(7):1190-1198. PubMed ID: 28518218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early onset epileptic encephalopathy caused by de novo SCN8A mutations.
    Ohba C; Kato M; Takahashi S; Lerman-Sagie T; Lev D; Terashima H; Kubota M; Kawawaki H; Matsufuji M; Kojima Y; Tateno A; Goldberg-Stern H; Straussberg R; Marom D; Leshinsky-Silver E; Nakashima M; Nishiyama K; Tsurusaki Y; Miyake N; Tanaka F; Matsumoto N; Saitsu H
    Epilepsia; 2014 Jul; 55(7):994-1000. PubMed ID: 24888894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex SCN8A DNA-abnormalities in an individual with therapy resistant absence epilepsy.
    Berghuis B; de Kovel CG; van Iterson L; Lamberts RJ; Sander JW; Lindhout D; Koeleman BP
    Epilepsy Res; 2015 Sep; 115():141-4. PubMed ID: 26220391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes.
    de Lange IM; Koudijs MJ; van 't Slot R; Gunning B; Sonsma ACM; van Gemert LJJM; Mulder F; Carbo EC; van Kempen MJA; Verbeek NE; Nijman IJ; Ernst RF; Savelberg SMC; Knoers NVAM; Brilstra EH; Koeleman BPC
    Epilepsia; 2018 Mar; 59(3):690-703. PubMed ID: 29460957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCN8A encephalopathy: Research progress and prospects.
    Meisler MH; Helman G; Hammer MF; Fureman BE; Gaillard WD; Goldin AL; Hirose S; Ishii A; Kroner BL; Lossin C; Mefford HC; Parent JM; Patel M; Schreiber J; Stewart R; Whittemore V; Wilcox K; Wagnon JL; Pearl PL; Vanderver A; Scheffer IE
    Epilepsia; 2016 Jul; 57(7):1027-35. PubMed ID: 27270488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.
    Estacion M; O'Brien JE; Conravey A; Hammer MF; Waxman SG; Dib-Hajj SD; Meisler MH
    Neurobiol Dis; 2014 Sep; 69():117-23. PubMed ID: 24874546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.
    Blanchard MG; Willemsen MH; Walker JB; Dib-Hajj SD; Waxman SG; Jongmans MC; Kleefstra T; van de Warrenburg BP; Praamstra P; Nicolai J; Yntema HG; Bindels RJ; Meisler MH; Kamsteeg EJ
    J Med Genet; 2015 May; 52(5):330-7. PubMed ID: 25725044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis.
    Butler KM; da Silva C; Shafir Y; Weisfeld-Adams JD; Alexander JJ; Hegde M; Escayg A
    Epilepsy Res; 2017 Jan; 129():17-25. PubMed ID: 27875746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCN1A clinical spectrum includes the self-limited focal epilepsies of childhood.
    Kivity S; Oliver KL; Afawi Z; Damiano JA; Arsov T; Bahlo M; Berkovic SF
    Epilepsy Res; 2017 Mar; 131():9-14. PubMed ID: 28192756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability.
    Kong W; Zhang Y; Gao Y; Liu X; Gao K; Xie H; Wang J; Wu Y; Zhang Y; Wu X; Jiang Y
    Epilepsia; 2015 Mar; 56(3):431-8. PubMed ID: 25785782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A de novo SCN8A heterozygous mutation in a child with epileptic encephalopathy: a case report.
    Lin KM; Su G; Wang F; Zhang X; Wang Y; Ren J; Wang X; Yao Y; Zhou Y
    BMC Pediatr; 2019 Nov; 19(1):400. PubMed ID: 31672125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
    Martin MS; Tang B; Papale LA; Yu FH; Catterall WA; Escayg A
    Hum Mol Genet; 2007 Dec; 16(23):2892-9. PubMed ID: 17881658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and de novo mutations in pediatric refractory epilepsy.
    Liu J; Tong L; Song S; Niu Y; Li J; Wu X; Zhang J; Zai CC; Luo F; Wu J; Li H; Wong AHC; Sun R; Liu F; Li B
    Mol Brain; 2018 Sep; 11(1):48. PubMed ID: 30185235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo SCN8A and inherited rare CACNA1H variants associated with severe developmental and epileptic encephalopathy.
    Stringer RN; Jurkovicova-Tarabova B; Souza IA; Ibrahim J; Vacik T; Fathalla WM; Hertecant J; Zamponi GW; Lacinova L; Weiss N
    Mol Brain; 2021 Aug; 14(1):126. PubMed ID: 34399820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach.
    Boerma RS; Braun KP; van den Broek MP; van Berkestijn FM; Swinkels ME; Hagebeuk EO; Lindhout D; van Kempen M; Boon M; Nicolai J; de Kovel CG; Brilstra EH; Koeleman BP
    Neurotherapeutics; 2016 Jan; 13(1):192-7. PubMed ID: 26252990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutations in sodium channel SCN1A and SCN2A predispose children to encephalopathy with severe febrile seizures.
    Saitoh M; Ishii A; Ihara Y; Hoshino A; Terashima H; Kubota M; Kikuchi K; Yamanaka G; Amemiya K; Hirose S; Mizuguchi M
    Epilepsy Res; 2015 Nov; 117():1-6. PubMed ID: 26311622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations.
    Bonanni P; Malcarne M; Moro F; Veggiotti P; Buti D; Ferrari AR; Parrini E; Mei D; Volzone A; Zara F; Heron SE; Bordo L; Marini C; Guerrini R
    Epilepsia; 2004 Feb; 45(2):149-58. PubMed ID: 14738422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous mutations in the SCN1A gene associated with genetic epilepsy with febrile seizures plus and Dravet syndrome in 2 families.
    Brunklaus A; Ellis R; Stewart H; Aylett S; Reavey E; Jefferson R; Jain R; Chakraborty S; Jayawant S; Zuberi SM
    Eur J Paediatr Neurol; 2015 Jul; 19(4):484-8. PubMed ID: 25795284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.